The effect of chemotherapy on the growing skeleton

Cancer Treatment Reviews

Volumn 26, Issue 5, 2000, Pages 363-376

  Van Leeuwen, B L ^a   Kamps, W A ^a   Jansen, H W B ^b   Hoekstra, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Bioscan   (Netherlands)

Author keywords

Chemotherapy; Growth; Skeleton

Indexed keywords

ALKALOID; ALKYLATING AGENT; ANTIBIOTIC AGENT; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOFOS; FLUOROURACIL; FOLIC ACID ANTAGONIST; IFOSFAMIDE; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; PACLITAXEL; TENIPOSIDE; VINBLASTINE;

AGE; BODY HEIGHT; BONE DISEASE; BONE GROWTH; BONE MINERALIZATION; BRAIN RADIATION; CANCER RADIOTHERAPY; CARTILAGE CELL; CHILDHOOD CANCER; CLINICAL FEATURE; CLINICAL TRIAL; DOSE RESPONSE; DRUG MECHANISM; FRACTURE; GROWTH PLATE; GROWTH RETARDATION; HUMAN; KIDNEY INJURY; NUTRITIONAL STATUS; OSTEOPOROSIS; PROTEIN EXPRESSION; RADIATION HAZARD; REVIEW; RICKETS; STEROID THERAPY;

EID: 0033790155     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1053/ctrv.2000.0180     Document Type: Review

References (220)

1. A rise in the incidence of childhood cancer in the United States
2. Recent trends in childhood cancer incidence and mortality in the United States
3. Long-term survival. Clinical care, research, and education
4. Late effects of immunosuppressive anticancer drugs
5. Neurobehavioural sequelae following cranial irradiation and chemotherapy in children: An analysis of risk factors
6. Late effects of cancer treatment in children
7. Avoiding chemotherapy related late effects in children with curable tumours
8. Cancer chemotherapy in infants and children
9. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein
10. Interaction of Ihh and BMP/Noggin signaling during cartilage differentiation
11. Common molecular pathways in skeletal morphogenesis and repair
12. PTH/PTHrP receptor in early development and Indian hedgehog regulated bone growth
13. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation
14. Functional analysis of the PTH/PTHrP network of ligands and receptors
15. Developmental patterning in chondrocytic cultures by morphogenic gradients: BMP induces expression of Indian hedgehog and Noggin
16. The parathyroid hormone/parathyroid hormone-related pepetide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation
17. Active role of chondrocyte apoptosis in endochondral ossification
18. Extracellular phosphate ions cause apoptosis of terminally differentiated epiphyseal chondrocytes
19. Cartilage to bone - Angiogenesis leads the way
20. Parathyroid hormone [PTH91-34] and parathyroid hormone-related protein [PTHrP(1-34)] promote reversion of hypertrophic chondrocytes to a prehypertrophic proliferating phenotype and prevent terminal differentiation of osteoblast-like cells
21. Chondrocyte death is linked to development of a mitochondrial membrane permeability transition in the growth plate
22. Newest knowledge of the growth plate
23. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
24. Molecular basis and clinical application of biological markers of bone turnover
25. Retinoic acid is a potent regulator of growth plate chondrogenesis
26. Endocrine regulation of longitudinal bone growth
27. The growth hormone insulin-like growth factor-I axis
28. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth
29. Demonstration of growth hormone receptors in cultured rat epiphyseal chondrocytes by specific binding of growth hormone and immunohistochemistry
30. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin
31. Growth hormone potentiates colony formation of epiphyseal chondrocytes in suspension culture
32. Regulation by GH of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied with insitu hybridization
33. Physical and biochemical factors in bone metabolism
34. Growth factors and the regulation of pre- and postnatal growth
35. Effect of growth hormone and insulin-like growth factor-I on DNA synthesis and matrix production in rat epiphyseal chondrocytes in monolayer culture
36. Regulation of growth in children with chronic illness. Therapeutic implications for the year 2000
37. Corticosteroids and growth
38. Growth retardation in chronic disease: Possible mechanisms
39. Growth and growth hormone status following treatment for childhood leukaemia
40. A study of the nutritional status of pediatric cancer patients
41. The effect of chemotherapy on growth in the skeletally immature individual
42. Nutritional support of the pediatric oncology patient
43. Update on somatomedin
44. Longitudinal bone growth: The growth plate and its dysfunction
45. 'Negative growth' in anorexia nervosa assessed by knemometry
46. The effects of acute infection and starvation on skeletal development. A study of young rats
47. Physical growth and bone age of survivors of protein energy malnutrition
48. Catch-up growth following illness or starvation
49. Growth, puberty and obesity after treatment for leukaemia
50. Growth of children with acute lymphocytic leukemia: Preliminary results
51. Height of children successfully treated for acute lymphoblastic leukemia: A report from the Late Effects Study Committee of Childrens Cancer Study Group
52. Growth of long term survivors of childhood malignancy
53. Effect of treatment of malignant disease on growth in children
54. Radiotherapy, chemotherapy, and growth-hormone deficiency
55. Complications of treatment encountered in lymphoma-leukemia long-term survivors
56. Is the risk of morbidity and rare mortality worth the cure?
57. Chronic neuroendocrinological sequelae of radiation therapy
58. Growth and endocrine disorders secondary to cranial irradiation
59. Late effects of childhood cancer therapy
60. Growth failure after treatment of pediatric brain tumors
61. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia
62. Growth hormone secretion in children after therapy for acute lymphoblastic leukaemia
63. Growth in children with acute lymphocytic leukemia: A Pediatric Oncology Group study
64. Growth and development of long-term survivors of childhood acute lymphoblastic leukemia treated with and without prophylactic radiation of the central nervous system
65. Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia
66. Growth disorders after cranial radiation in childhood
67. Shortened and diminished pubertal growth in boys and girls treated for acute lymphoblastic leukaemia
68. Disturbed pubertal growth in girls treated for acute lymphoblastic leukemia
69. Suppressed spontaneous secretion of growth hormone in girls after treatment for acute lymphoblastic leukaemia
70. Impaired pubertal growth in acute lymphoblastic leukaemia
71. Longitudinal growth and final height in long-term survivors of childhood leukaemia
72. Late effects of central nervous system treatment of acute lymphoblastic leukemia in childhood are sex-dependent
73. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia
74. Clinical characteristics and factors affecting growth in long-term survivors of cancer
75. Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation
76. Growth after treatment of solid tumours in childhood
77. Reduced bone mineral density in long-term survivors of medulloblastoma
78. Longitudinal evaluation of bone mineral density in children receiving chemotherapy
79. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma
80. Bone mineral density in long-term survivors of childhood cancer
81. Bone density in survivors of childhood malignancies
82. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia
83. Survivors of childhood cancer: Long-term endocrine and metabolic problems dwarf the growth disturbance
84. Long-term sequelae of therapy for childhood acute lymphoblastic leukaemia
85. Bone fragility induced by X-ray irradiation in relation to cortical bone-mineral content
86. The effect of irradiation upon the composition and vascularity of growing rat bones
87. The effect of roentgen irradiation on epiphyseal growth
88. The effect of radiation on the fracture repair process. A biomechanical evaluation of a closed fracture in a rat model
89. Effects of radiation therapy on growing long bones
90. Late effects of treatment for germ cell tumors during childhood and adolescence
91. Late effects of early childhood cancer therapy
92. Radiation fractionation sensitivity of epiphyseal cartilage in a weanling rat model
93. Decreased bone growth arrest in weanling rats with multiple radiation fractions per day
94. Radiation induced dysplasias of bone
95. Effect of local irradiation on longitudinal bone growth in the rat. A tetracycline labelling investigation
96. Growth in children following irradiation for bone marrow transplantation
97. Wachstumsstorungen durch Schadigung der Epiphysenfuge im Kindesalter infolge therapeutische Radiatio
98. Health status of young childen with cancer following discontinuation of therapy
99. Pediatric radiotherapy. An overview
100. The effect of administered corticosteroids on the growth of children
101. Corticosteroids and growth
102. Growth and skeletal maturation in asthmatic children: Effect of corticosteriod treatment
103. Corticosteroid-induced bone loss in men
104. Growth-hormone secretion: The role of glucocorticoids
105. Mechanisms of glucocorticoid inhibition of growth
106. The effects of different steroids on costal and epiphyseal cartilage of fetal and adult rats
107. Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation
108. Effect of inhaled corticosteroids on bones and growth
109. Glucocorticoid osteoporosis - Mechanisms and management
110. Incidence of cancer in children in the United States
111. Pediatric oncology
112. General principles of chemotherapy
113. Molecular and cellular effects of methotrexate
114. Induction of apoptotsis in neoplastic cells by anthracycline antitumor drugs: Nuclear and cytoplasmic triggering?
115. Treatment of leukemia and allied disorders with folic acid antagonists; effect of aminopterin on skeletal lesions
116. Some observations on bone growth, with particular respect to zones and transverse lines of increased density in the metaphysis
117. Growth slowdown and arrest lines
118. Radiological evidence of growth in children with acute leukemia treated with folic acid antagonists
119. Growth effects of long-term antileukemic therapy
120. Non-oncogenic sequelae of cancer chemotherapy
121. Disorders of the endocrine system due to radiation and cytotoxic chemotherapy
122. Growth in children treated for acute lymphoblastic leukemia with and without prophylactic cranial irradiation
123. Endocrine sequelae of cancer therapy
124. Effect of chemotherapy on human growth plate
125. Pediatric nasopharyngeal carcinoma: Long term follow-up of 29 patients
126. Effect of chemotherapy on growth
127. Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia
128. Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia
129. Effect of treatment of malignant disease on growth in children
130. Growth in children treated for acute lymphoblastic leukaemia
131. Growth and growth hormone secretion after treatment for childhood non-Hodgkin's lymphoma
132. Chemotherapy plays a major role in the inhibition of catch-up growth during maintenance therapy for childhood acute lymphoblastic leukemia
133. Doxorubicin is a potent inhibitor of interleukin 1 induced cartilage proteoglycan resorption in-vitro
134. Glucocorticoid pretreatment reduces the cytotoxic effects of a variety of DNA-damaging agents on rat tibial growth-plate chondrocytes in vitro
135. The effects of radiation therapy on bone growth
136. Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia
137. On vertebral body growth
138. Growth, differentiation, and disease
139. The short- and long-term effects of methotrexate on the rat skeleton
140. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: A 1-year prospective study
141. Disturbance in bone turnover in children with a malignancy at completion of chemotherapy
142. Reduced bone density at completion of chemotherapy for a malignancy
143. Effects of a third intensification block of chemotherapy on bone and collagen turnover, insulin-like growth factor I, its binding proteins and short-term growth in children with acute lymphoblastic leukaemia
144. Bone mass after treatment for acute lymphoblastic leukemia in childhood
145. Impaired development of bone mineral density during chemotherapy: A prospective analysis of 46 children newly diagnosed with cancer
146. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia
147. The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats
148. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia
149. The effect of methotrexate on mouse bone cells in culture
150. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model
151. Comparison of the effects of adriamycin and methotrexate on orthotopic and induced heterotopic bone in rats
152. Methotrexate effects on heterotopic bone in rats
153. Effect of the antineoplastic agent methotrexate on experimental heterotopic new bone formation in rats
154. Bone mineral density in children with acute lymphoblastic leukaemia
155. Care and treatment of long-term survivors of childhood cancer
156. Hypocalcemia in cancer
157. Effects of cisplatin on parathyroid hormone- and human lung tumor-induced bone resorption
158. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia
159. Late effects of treatment of cancer in children
160. Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems
161. Toxic effects of cis-dichlorodiammineplatinum (II) in man
162. Effects of magnesium on skeletal metabolism
163. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia
164. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia
165. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: Influence of disease, drugs and nutrition
166. Ifosfamide and paediatrics: Should this marriage be saved?
167. Ifosfamide nephrotoxicity in paediatric cancer patients
168. Renal function abnormalities after ifosfamide treatment in children
169. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children
170. Development of ifosfamide-induced nephrotoxicity: Prospective follow-up in 75 patients
171. Rickets - A complication of ifosfamide chemotherapy for Wilms tumor
172. Ifosfamide, mesna, and nephrotoxicity in children
173. Ifosfamide, Fanconi's syndrome, and rickets
174. Hypophosphataemic rickets after ifosfamide treatment in children
175. The development of rickets as a complication of chemotherapy for the treatment of Wilms' tumor
176. Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome - A report of two cases
177. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor
178. Ifosfamide-induced Fanconi syndrome
179. Relative osteopenia after treatment for acute lymphoblastic leukemia
180. Bone mineral density in young adult survivors of childhood cancer
181. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood
182. Bone mineral status during and after therapy of childhood cancer: An increasing population with multiple risk factors for impaired bone health
183. Daily energy expenditure and physical activity in survivors of childhood malignancy
184. Role of physical activity in the development of skeletal mass in children
185. Ewing's sarcoma, adjuvant chemotherapy and pathologic fracture
186. A pertrochanteric fracture in an adolescent treated for an osteogenic sarcoma of the shaft of the femur with chemotherapy, tumour resection and endoprosthesis
187. Osteoporotic fractures secondary to methotrexate therpay of acute leukemia in remission
188. Fractures in children treated with methotrexate for leukemia
189. Clinical and pathologic features of chronic adriamycin toxicosis in rabbits
190. Acute and late effects on normal tissues following combined chemo- and radiotherapy for childhood rhabdomyosarcoma and Ewing's sarcoma
191. Slipped capital femoral epiphysis following radiotherapy and chemotherapy
192. Slipped capital femoral epiphysis following radiotherapy
193. Slipped capital femoral epiphysis (SCFE) following pelvic irradiation for rhabdomyosarcoma
194. The Franz Buschke lecture: Late effects of chemotherapy and radiation therapy: A new hypothesis
195. Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumourresection and endoprosthesis: Report of four fractures in two children
196. Slipped upper femoral epiphysis after radiotherapy
197. Slipped capital femoral epiphysis following radiation and chemotherapy
198. Aseptic osteonecrosis in children treated for acute lymphoblastic leukemia and aplastic anemia
199. Osteonecrosis of the femoral head in patients with lymphoma treated with intermittent combination chemotherapy (including corticosteroids)
200. Osteonecrosis after chemotherapy
201. Avascular necrosis of bone caused by combination chemotherapy without corticosteroids
202. Bone scintigraphy: Methotrexate associated bone necrosis
203. Osteonecrosis of bone associated with combination chemotherapy without corticosteroids
204. Osteonecrosis in Hodgkin's disease
205. Avascular necrosis of bone following combination chemotherapy for acute lymphocytic leukemia
206. Etiology and pathogenesis of osteonecrosis
207. Skeletal complications in pediatric oncology patients
208. Effects of pediatric cancer therapy on the musculoskeletal system
209. Methotrexate osteopathy in patients with osteosarcoma
210. Methotrexate osteopathy
211. The effects of methotrexate (MTX) on bone. A densitometric study conducted on 59 patients with MTX administered at different doses
212. Methotrexate-induced bone pain in childhood leukemia
213. Childhood cancer survivors. Past, present, and future
214. Oncogenesis and other late effects of cancer treatment in children
215. Forty-year experience with second malignancies after treatment of childhood cancer: Analysis of outcome following the development of the second malignancy
216. Bone sarcomas linked to radiotherapy and chemotherapy in children
217. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer
218. Science, medicine, and the future. Antivascular therapy: A new approach to cancer treatment
219. The rationale and future potential of angiogenesis inhibitors in neoplasia